185 related articles for article (PubMed ID: 28214830)
41. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Wierzbicki PM; Bodek G; Sulik M; Kmiec Z
Int J Oncol; 2015 Sep; 47(3):951-62. PubMed ID: 26134521
[TBL] [Abstract][Full Text] [Related]
42. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
[TBL] [Abstract][Full Text] [Related]
43. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
44. Very long-chain fatty acids are accumulated in triacylglycerol and nonesterified forms in colorectal cancer tissues.
Hama K; Fujiwara Y; Hayama T; Ozawa T; Nozawa K; Matsuda K; Hashiguchi Y; Yokoyama K
Sci Rep; 2021 Mar; 11(1):6163. PubMed ID: 33731797
[TBL] [Abstract][Full Text] [Related]
45. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
46. Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.
Löfroos AB; Kadivar M; Resic Lindehammer S; Marsal J
Eur J Med Res; 2017 Oct; 22(1):40. PubMed ID: 29020986
[TBL] [Abstract][Full Text] [Related]
47. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
48. Determination of red blood cell fatty acid profiles: Rapid and high-confident analysis by chemical ionization-gas chromatography-tandem mass spectrometry.
Schober Y; Wahl HG; Renz H; Nockher WA
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():1-7. PubMed ID: 27880928
[TBL] [Abstract][Full Text] [Related]
49. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
Zeng J; Tang ZH; Liu S; Guo SS
World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
[TBL] [Abstract][Full Text] [Related]
51. Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.
Kowalczyk AE; Godlewski J; Krazinski BE; Kiewisz J; Sliwinska-Jewsiewicka A; Kwiatkowski P; Pula B; Dziegiel P; Janiszewski J; Wierzbicki PM; Kmiec Z
Tumour Biol; 2015 Jun; 36(6):4441-52. PubMed ID: 25874491
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.
Miyata Y; Kumagai K; Nagaoka T; Kitaura K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Cancer Biomark; 2015; 15(6):789-97. PubMed ID: 26406403
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
[TBL] [Abstract][Full Text] [Related]
54. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
55. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
56. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract][Full Text] [Related]
57. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
58. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
59. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
60. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J
Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
